Chemotherapy and chemoradiotherapy for adenocarcinoma of the esophagus and junction with oligometastases: Results of the TNT-OES-1 trial.
Charlène J. van der Zijden(Erasmus MC Cancer Institute), Sjoerd M. Lagarde(University of Amsterdam), Manon C.W. Spaander(Erasmus University Rotterdam), Leni van Doorn(Erasmus MC), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Ben M. Eyck(Erasmus MC Cancer Institute), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Joost J. Nuyttens(Erasmus MC Cancer Institute), Bas P. L. Wijnhoven(Inserm), Ate van der Gaast(Erasmus MC), Lindsey Oudijk(Erasmus MC), Tamara J. Huizer(Erasmus MC Cancer Institute), Bianca Mostert(Erasmus MC)
Cited by 1
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
|Annals of Surgery|2007|709
Paediatric Gastrointestinal Endoscopy
|Journal of Pediatric Gastroenterology and Nutrition|2016|274